Scientists get online news aggregator

  title={Scientists get online news aggregator},
  author={D. Butler},
  • D. Butler
  • Published 25 June 2008
  • Computer Science, Medicine
  • Nature
Idec, a prominent US biotechnology firm, ended last week when shareholders rejected billionaire investor Carl Icahn’s bid to oust three members of the company’s board of directors. The decision was a clear defeat for Icahn’s plan to gain control of the company, which is based in Cambridge, Massachusetts, and a victory in Biogen’s struggle to remain independent. The fight between Icahn (pictured) and Biogen began last August, when Icahn announced that he had acquired 1% of the company’s stock…